Effects of intravenously administered β-human atrial natriuretic polypeptide in humans

Hiroshi Itoh, Kazuwa Nakao, Masashi Mukoyama, Shozo Shiono, Narito Morii, Akira Sugawara, Takayuki Yamada, Yoshihiko Saito, Hiroshi Arai, Klminori Hosoda, Yoshikazu Kambayashi, Ken Inouye, Hlroo Imura

研究成果: Article査読

13 被引用数 (Scopus)


β-Human atrial natriuretic polypeptide (β-hANP) is an antiparallel dimer of α-human ANP (a-hANP) that was isolated from human atria. Using synthetic β-hANP and a radioimmunoassay for α-hANP that also detects β-hANP, we have previously demonstrated that β-hANP is converted into α-hANP in human plasma in vitro. In the present study, we compared the effects of intravenous administration of β-hANP (100 μg) to five normal human volunteers with those of an equimolar administration of α-hANP (50 μg) to the same subjects, and we also investigated the possible mechanisms of actions of β-hANP. Although the administration of α-hANP caused a significant decrease in blood pressure with a reactional increase of heart rate, β-hANP elicited minimal change of blood pressure. In contrast, β-hANP exerted more potent and longer lasting diuretic and natriuretic activities than did α-hANP. Net changes in urine volume and sodium excretion induced by β-hANP (579 ± 65 ml, 56.0 ± 9.9 mEq) were significantly greater than those elicited by α-hANP (396 ± 50 ml, 34.7 ± 4.9 mEq; p < 0.05, respectively). The administration ofβ-hANP revealed a longer retention of the ANP-like immunoreactivity level in plasma, compared with that of α-hANP. High performance gel permeation chromatography coupled with the radioimmunoassay revealed that β-hANP (Afr=6000) was also converted into α-hANP (Mr=3000) in human plasma in vivo. The demonstrated conversion of β-hANP into α-hANP could be relevant to the observed effects of β-hANP in humans.

出版ステータスPublished - 1988 6月

ASJC Scopus subject areas

  • 内科学


「Effects of intravenously administered β-human atrial natriuretic polypeptide in humans」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。